Summary
Prenalterol, a cardio selective beta adrenergic receptor antagonist was given perorally in doses from 20–150 mg/day in three patients with dialysis associated hypotension. No effect on blood-pressure was seen over several months during this treatment.
This is a preview of subscription content, log in via an institution to check access.
References
While RP, Sullivan JF, Stenzel KH, Rutzin AL (1979) Blood pressure control in chronic dialysis patients. In: Drukker W, Parsons FM, Maher JF (eds) Replacement of renal function by dialysis. Martinus Nijhoff, London, pp 504–518
Johnsson C, Jordö L, Lundborg P, Rönun O, Welin-Fogelberg L, Wikstrand J (1978) Haemodynamic and tolerance studies in man of a new orally active selective β1-adrenoceptor agonist. Eur J Clin Pharmacol 13: 163–170
Scott DHT, Arthur GR, Boyes RN, Scott DB (1979) Cardiovascular effects of prenalterol (HI33/22) in normal man. Br J Clin Pharmacol 7: 365–370
Kersh ES, Kronfield SJ, Unger A, Popper RW, Cantor S, Cohn K (1974) Autonomic insufficiency in uremia as a cause of hemodialysis-induced hypotension. N Engl J Med 290: 650–653
Tyler HR (1968) Neurologic disorders in renal failure. Am J Med 44: 734–748
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ladefoged, J. Lack of effect of prenalterol on dialysis — Associated hypotension. Eur J Clin Pharmacol 26, 399–400 (1984). https://doi.org/10.1007/BF00548774
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00548774